1. What 5 Analyst Ratings Have To Say About Foghorn Therapeutics

    By Benzinga Insights Over the past 3 months, 5 analysts have published their opinion on Foghorn Therapeutics (NASDAQ: FHTX ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade o
  2. Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    By Lisa Levin Gainers Addentax Group Corp. (NASDAQ: ATXG ) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms. CymaBay Therapeutics, Inc. (NASDAQ: CBAY ) surged 40% to $10
  3. Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday

    By Lisa Levin Keybanc boosted the price target for Micron Technology, Inc. (NASDAQ: MU ) from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market trading. Credit Suisse cut the price target for Pfizer Inc. (NYSE: PFE